https://www.reuters.com/business/healthcare-pharmaceuticals/german-drug-regulator-considering-export-ban-ozempic-2023-11-15/
0
0
11/15/23 at 11:46am
Organization
Reuters
Author
Ludwig Burger
Germany's drug regulator BfArM is considering an export ban on Novo Nordisk's <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> diabetes drug Ozempic, which is in high demand for its weight-loss benefits, as European …
Create an account
or login to join the discussion